Browse All

Current Filters

CLEAR FILTER x

TITLE

The Effects of Lecanemab Treatment on Soluble CSF Aß Protofibrils (PF) in Clarity AD

Author:Horie, Kanta   Koyama, Akihiko   Sachdev, Pallavi   Shuta, Kazuyoshi   Tahara, Kazuhiro   Kanekiyo, Michio   Dhadda, Shobha   Reyderman, Larisa   Hersch, Steven   Irizarry, Michael   Kramer, Lynn   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Movement Disorders  

Program Number:S1.003  

Author Institution:

Clinical Profile for Lecanemab Subcutaneous Formulation for Treatment Initiation and Maintenance in Early Alzheimer’s Disease (AD)

Author:Cohen, Sharon   Hersch, Steven   Penner, Natasha   Bhagunde, Pratik   Reyderman, Larisa   Patten, Anna   Dhadda, Shobha   Irizarry, Michael   Kramer, Lynn   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S1.004  

Author Institution:

The Lecanemab Clarity AD Open-label Extension in Early Alzheimer’s Disease: Initial Findings from the 48-month Analysis

Author:van Dyck, Christopher   Sperling, Reisa   Li, David   Kanekiyo, Michio   Dhadda, Shobha   Hersch, Steven   Gee, Michelle   Irizarry, Michael   Kramer, Lynn   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S1.005  

Author Institution: